Navigation Links
Prix Galien USA Announces 2009 Final Candidates
Date:8/7/2009

ce for the amount of research and level of skill that was invested in the development of these products that improve lives," said Gerald Weissmann, M.D., Prix Galien USA committee chair, New York University professor emeritus and editor-in-chief of The FASEB Journal.

Prix Galien USA honorees are judged on the basis of the innovative nature of the development, application or clinical utility of the drug or technology and whether its discovery can be applied to future biomedical science.

In 2008, the Prix Galien USA committee recognized Selzentry(TM)( )(Pfizer Inc.), Isentress(R) (Merck & Co., Inc.), Soliris(R) (Alexion Pharmaceuticals, Inc.), INFUSE(R) (Wyeth) and Revlimid(R)( )(The Celgene Corporation).

The Prix Galien USA award is considered the industry's highest accolade for pharmaceutical research and development -- equivalent to the Nobel Prize. The award committee comprises 11 individuals including seven Nobel Laureates, founders of major biotech companies and editors of world-renowned biology journals. For details about the Prix Galien USA award and committee visit www.prix-galien-usa.com.


'/>"/>
SOURCE Prix Galien USA
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Prix Galien USA Announces 2008 Final Candidates
2. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
3. Alexions Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product
4. 2009 Prix Galien USA Now Accepting Nominations for Top Prize in Biopharmaceutical Research and Development
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
7. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
8. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
9. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
10. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... YORK , May 22, 2013   ... the development of disease modifying therapeutics for Alzheimer,s ... the completion of its Series B financing, which ... and warrants that would represent approximately $2.8M in ... and new investors supported the raise. ...
(Date:5/22/2013)... 22, 2013  Superior Controls, Inc. has been ... Business NH Magazine.  For the past 22 years, ... distinguish themselves with extraordinary business and civic excellence. ... this honor," said Rick Pierro ... recognition, this award is a reflection of Superior ...
(Date:5/22/2013)... Switzerland (PRWEB) May 22, 2013 ... for industrial biotechnology, drug discovery, and life science ... Genedata Selector ™ as its bioinformatics platform ... production-relevant organisms. Genedata will provide AB Enzymes, one ... with a hosted solution of Genedata Selector accompanied ...
(Date:5/22/2013)... Ontario (PRWEB) May 22, 2013 ... advanced sound therapy for tinnitus treatment. AudioNotch is ... Hearing . With clinic locations in both British ... provider of audiology and hearing services. AudioNotch's tinnitus ... locations. , Upon entering a Destination Hearing clinic, ...
Breaking Biology Technology:Oligomerix, Inc. Completes Series B Financing 2Oligomerix, Inc. Completes Series B Financing 3Superior Controls of Seabrook, NH named Business of the Year for 2013 by Business NH Magazine 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 3AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 4AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing 2
... of Investment Success -, GAITHERSBURG, Md., Jan. ... of AstraZeneca plc (LSE: AZN.L, NYSE:,AZN), today announced ... will broaden its focus to include areas of ... areas of,cardiovascular and metabolic disease, pain and central ...
... 7 Boston Scientific,Corporation (NYSE: BSX ) today ... Surgery and Vascular Surgery businesses to the Getinge Group ... the definitive agreement,announced on November 5, 2007., The ... in connection with the transaction. These charges will be ...
... MONICA, Calif., Jan. 7 Aida,Pharmaceuticals, Inc. (OTC ... an award from the Science and Technology Department ... China and known throughout,the country for its focus ... because of its "clinical research and,commercialization of Rh-Apo2L" ...
Cached Biology Technology:MedImmune Broadens Focus of Venture Capital Fund to Include New Therapeutic Areas 2MedImmune Broadens Focus of Venture Capital Fund to Include New Therapeutic Areas 3Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses 2Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses 3Aida Receives Chinese Government Innovation Award 2
(Date:5/22/2013)... in a major new effort to educate the public ... people with clean water that looms ahead in the ... in the current edition of Chemical & Engineering ... Society (ACS), the world,s largest scientific society. , Bassam ... L. Schnoor, Ph.D., explain that shortages of reliable supplies ...
(Date:5/22/2013)... bacteria is responsible for legionellosis, an infectious disease that ... this pathogen has developed a complex method enabling it ... thus avoiding these acting against the infectious bacteria. , ... bioGUNE, in which teams from the National Institute of ... Centre in Barcelona (BSC) have also participated, has described ...
(Date:5/21/2013)... known for a long time that some creatures evolve ... particularly for plants. But it may be that height ... University and the U. S. National Evolutionary Synthesis Center. ... May in the journal Nature Communications , Lanfear ... , Drawing from a database of global patterns in ...
Breaking Biology News(10 mins):Mechanism discovered which aids Legionella to camouflage itself in the organism 2Small but speedy: Short plants live in the evolutionary fast lane 2
... Max Delbrck Center for Molecular Medicine (MDC) Berlin is to ... Prize. The announcement was made by the German Research Foundation ... time the prize will go to the MDC. In 2002 ... will be awarded to a total of eleven scientists: two ...
... mouse model to investigate allergy to fenugreek has been developed ... study cross-reactivity to peanut, soy and lupin, major food allergens ... of the legume family and is used as an ingredient ... be severe yet its presence is rarely declared in ingredient ...
... that are twisted are ubiquitous in nature, and have important ... have unique and technologically useful optical properties; the medicinal properties ... within us think of the double helix twisted ... is called chirality and researchers at Case Western Reserve University ...
Cached Biology News:Nikolaus Rajewsky of the MDC to receive the Leibniz Prize 2New food allergy model for fenugreek developed 2Twisting molecules by brute force: A top-down approach 2Twisting molecules by brute force: A top-down approach 3
... This antibody recognizes murine IRF7 ... with other related IRF proteins. ... murine IRF7 protein was confirmed ... the 293T cells transfected with ...
...
EMBP (FL-222)...
Rabbit anti-T-box 6...
Biology Products: